A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells

Anna De Blasio, Giovanni Pratelli, Riccardo Di Fiore, Riccardo Di Fiore, Christian Saliba, Shawn Baldacchino, Renza Vento, Giovanni Tesoriere, Christian Scerri, Godfrey Grech, Rosa Drago Ferrante

Risultato della ricerca: Article

3 Citazioni (Scopus)

Abstract

The present study shows that nuclear factor erythroid 2-related factor 2 (NRF2) and miR-29b-1-5p are two opposite forces which could regulate the fate of MDA-MB-231 cells, the most studied triple-negative breast cancer (TNBC) cell line. We show that NRF2 activation stimulates cell growth and markedly reduces reactive oxygen species (ROS) generation, whereas miR-29b-1-5p overexpression increases ROS generation and reduces cell proliferation. Moreover, NRF2 downregulates miR-29b-1-5p expression, whereas miR-29b-1-5p overexpression decreases p-AKT and p-NRF2. Furthermore, miR-29b-1-5p overexpression induces both inhibition of DNA N-methyltransferases (DNMT1, DNMT3A, and DNMT3B) expression and re-expression of HIN1, RASSF1A and CCND2. Conversely, NRF2 activation induces opposite effects. We also show that parthenolide, a naturally occurring small molecule, induces the expression of miR-29b-1-5p which could suppress NRF2 activation via AKT inhibition. Overall, this study uncovers a novel NRF2/miR-29b-1-5p/AKT regulatory loop that can regulate the fate (life/death) of MDA-MB-231 cells and suggests this loop as therapeutic target for TNBC.
Lingua originaleEnglish
pagine (da-a)629-637
Numero di pagine9
RivistaJournal of Cellular Physiology
Volume235
Stato di pubblicazionePublished - 2020

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Physiology
  • Clinical Biochemistry
  • Cell Biology

Cita questo

De Blasio, A., Pratelli, G., Di Fiore, R., Di Fiore, R., Saliba, C., Baldacchino, S., Vento, R., Tesoriere, G., Scerri, C., Grech, G., & Drago Ferrante, R. (2020). A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells. Journal of Cellular Physiology, 235, 629-637.